Cellosaurus SUP-HD1 (CVCL_2208)

Cell line name SUP-HD1
Synonyms Sup-HD1; SUP-HD-1; SUPHD1
Accession CVCL_2208
Resource Identification Initiative To cite this cell line use: SUP-HD1 (RRID:CVCL_2208)
Comments Part of: Cancer Cell Line Encyclopedia (CCLE) project.
Doubling time: ~40-80 hours (DSMZ).
Microsatellite instability: Instable (MSI-low) (Sanger).
Omics: Deep exome analysis.
Omics: DNA methylation analysis.
Omics: SNP array analysis.
Omics: Transcriptome analysis.
Disease Hodgkin lymphoma (NCIt: C9357)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Category Cancer cell line
STR profile Source(s): Cosmic-CLP; DSMZ

Markers:
AmelogeninX
CSF1PO10,11
D13S31711,12
D16S53910
D5S81811,12
D7S82010,12 (Cosmic-CLP)
10,11,12 (DSMZ)
TH019.3
TPOX8,11
vWA14,19
Publications

PubMed=2554995
Naumovski L., Utz P.J., Bergstrom S.K., Morgan R., Molina A., Toole J.J., Glader B.E., McFall P., Weiss L.M., Warnke R., Smith S.D.
SUP-HD1: a new Hodgkin's disease-derived cell line with lymphoid features produces interferon-gamma.
Blood 74:2733-2742(1989)

PubMed=22460905; DOI=10.1038/nature11003
Barretina J.G., Caponigro G., Stransky N., Venkatesan K., Margolin A.A., Kim S., Wilson C.J., Lehar J., Kryukov G.V., Sonkin D., Reddy A., Liu M., Murray L., Berger M.F., Monahan J.E., Morais P., Meltzer J., Korejwa A., Jane-Valbuena J., Mapa F.A., Thibault J., Bric-Furlong E., Raman P., Shipway A., Engels I.H., Cheng J., Yu G.K., Yu J., Aspesi P. Jr., de Silva M., Jagtap K., Jones M.D., Wang L., Hatton C., Palescandolo E., Gupta S., Mahan S., Sougnez C., Onofrio R.C., Liefeld T., MacConaill L., Winckler W., Reich M., Li N., Mesirov J.P., Gabriel S.B., Getz G., Ardlie K., Chan V., Myer V.E., Weber B.L., Porter J., Warmuth M., Finan P., Harris J.L., Meyerson M., Golub T.R., Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Nature 483:603-607(2012)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X., Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

Cross-references
Cell line collections DSMZ; ACC-574
Cell line databases/resources CCLE; SUPHD1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
Cosmic-CLP; 1331039
GDSC; 1331039
LINCS_LDP; LCL-2014
Biological sample resources BioSample; SAMN03473483
Gene expression databases GEO; GSM552469
GEO; GSM887659
GEO; GSM888751
GEO; GSM1670492
Polymorphism and mutation databases Cosmic; 1086360
Cosmic; 1278831
Cosmic; 1432043